Jeremy Bender - Net Worth and Insider Trading

Jeremy Bender Net Worth

The estimated net worth of Jeremy Bender is at least $12 Million dollars as of 2025-07-14. Jeremy Bender is the CHIEF EXECUTIVE OFFICER of Day One Biopharmaceuticals Inc and owns about 1,754,575 shares of Day One Biopharmaceuticals Inc (DAWN) stock worth over $12 Million. Details can be seen in Jeremy Bender's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeremy Bender has not made any transactions after 2025-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Jeremy Bender

To

Jeremy Bender Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeremy Bender owns 2 companies in total, including Day One Biopharmaceuticals Inc (DAWN) , and Fusion Pharmaceuticals Inc (FUSN) .

Click here to see the complete history of Jeremy Bender’s form 4 insider trades.

Insider Ownership Summary of Jeremy Bender

Ticker Company Transaction Date Type of Owner
DAWN Day One Biopharmaceuticals Inc 2025-05-16 director & Chief Executive Officer
FUSN Fusion Pharmaceuticals Inc 2023-10-16 director

Jeremy Bender Latest Holdings Summary

Jeremy Bender currently owns a total of 1 stock. Jeremy Bender owns 1,754,575 shares of Day One Biopharmaceuticals Inc (DAWN) as of May 16, 2025, with a value of $12 Million.

Latest Holdings of Jeremy Bender

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DAWN Day One Biopharmaceuticals Inc 2025-05-16 1,754,575 6.90 12,106,568

Holding Weightings of Jeremy Bender


Jeremy Bender Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeremy Bender has made a total of 25 transactions in Day One Biopharmaceuticals Inc (DAWN) over the past 5 years, including 0 buys and 25 sells. The most-recent trade in Day One Biopharmaceuticals Inc is the sale of 13,964 shares on May 16, 2025, which brought Jeremy Bender around $87,415.

Insider Trading History of Jeremy Bender

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeremy Bender Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeremy Bender Ownership Network

Ownership Network List of Jeremy Bender

No Data

Ownership Network Relation of Jeremy Bender

Insider Network Chart


Jeremy Bender Owned Company Details

What does Day One Biopharmaceuticals Inc do?

Who are the key executives at Day One Biopharmaceuticals Inc?

Jeremy Bender is the director & Chief Executive Officer of Day One Biopharmaceuticals Inc. Other key executives at Day One Biopharmaceuticals Inc include COO & CFO and Secretary York Charles N Ii , Chief Medical Officer Samuel C. Blackman , and 10 percent owner Ai Day 1 Llc .

Day One Biopharmaceuticals Inc (DAWN) Insider Trades Summary

Over the past 18 months, Jeremy Bender made 7 insider transaction in Day One Biopharmaceuticals Inc (DAWN) with a net sale of 141,946. Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 238,963 shares made by Samuel C. Blackman , a net sale of 79,689 shares made by York Charles N Ii , and a net sale of 22,060 shares made by Adam Dubow .

In summary, during the past 3 months, insiders sold 26,725 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 26,725 shares. During the past 18 months, 496,585 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 496,585 shares.

Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Day One Biopharmaceuticals Inc Insider Transactions

No Available Data

Jeremy Bender Mailing Address

Above is the net worth, insider trading, and ownership report for Jeremy Bender. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jeremy Bender's mailing address is: South San Francisco Ca 94080.